a 3253 has been researched along with Nomega-hydroxy-nor-l-arginine in 1 studies
| Studies (a 3253) | Trials (a 3253) | Recent Studies (post-2010) (a 3253) | Studies (Nomega-hydroxy-nor-l-arginine) | Trials (Nomega-hydroxy-nor-l-arginine) | Recent Studies (post-2010) (Nomega-hydroxy-nor-l-arginine) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 6 | 0 | 6 |
| Protein | Taxonomy | a 3253 (IC50) | Nomega-hydroxy-nor-l-arginine (IC50) |
|---|---|---|---|
| Arginase-1 | Homo sapiens (human) | 3.68 | |
| Arginase-1 | Rattus norvegicus (Norway rat) | 1.4 | |
| Arginase-1 | Bos taurus (cattle) | 2.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardey, B; Desingle, C; Foley, S; Girard, C; Grzybowski, M; Harakat, D; Muller, J; Pomper, P; Pudlo, M; Ramseyer, C; Zedet, A | 1 |
1 other study(ies) available for a 3253 and Nomega-hydroxy-nor-l-arginine
| Article | Year |
|---|---|
Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors.
Topics: | 2020 |